Genetics

Study sheds light on role of mutations in metastasized cancer

Approximately 95 percent of cancer mortality is caused by metastasis. This fact is what motivates many cancer researchers to focus on finding new ways to stop or kill the growth of metastatic cancer cells. A new paper published ...

Oncology & Cancer

T-cell interactions vary between tumor microenvironments

A team led by Northwestern Medicine investigators has discovered differences in the distribution and interaction of T-cells within the microenvironment of different regions of both brain tumors and brain metastases, according ...

Oncology & Cancer

ASCO: Cabozantinib improves progression-free survival in RCC

(HealthDay)—For patients with advanced renal cell carcinoma, cabozantinib is associated with improved progression-free survival (PFS), with consistent improvement across all patient subgroups, according to a study scheduled ...

Oncology & Cancer

Grant to fuel baking soda cancer therapy research

A $2 million grant from the National Institutes of Health will enable University of Arizona biomedical engineering researchers to improve the way doctors measure the effectiveness of drinking baking soda to fight breast cancer.

Oncology & Cancer

More radionuclide therapy is better for prostate cancer patients

For prostate cancer patients with bone metastases, repeated administrations of radionuclide therapy with 188Re-HEDP are shown to improve overall survival rates and reduce pain, according to new research published in the November ...

Oncology & Cancer

Fighting melanoma's attraction to the brain

(Medical Xpress)—The process of metastasis, by which cancer cells travel from a tumor site and proliferate at other sites in the body, is a serious threat to cancer patients. According to the National Cancer Institute, ...

page 6 from 39